Research and development path of new Tibetan medicine based on the transformation of Tibetan medicine knowledgeCHEN Wei-wu, PUQIONG Ci-ren, BAIMA Ci-ren, BIANBA Ci-ren, ZANG Ke-cheng721-728
Discussion on project-establishment of R&D of new traditional Chinese medicines and their clinical advantages in treating tumors based on cancer-related fatiguePAN Guo-feng, FENG Hong, QIN Xiao-long, JIANG Min, LI Fang729-733
Considerations on pharmaceutical evaluation of adenovirus-based vector therapeutic productsXU Long-chang, CUI Jing, WEI Wei734-739
Strategy and cases of preclinical safety evaluation of chimeric antigen receptor T cells productsHUANG Ying, HOU Tian-tian, WEN Hai-ruo, QIN Chao, HUO Yan740-745
Research progress on application of extracellular vesicles derived from immune cells in tumor therapyLI Ai-xue, SHI Tong, LI Yi-xiu, ZHAO Yu-nan, JIANG Liang-di, GU Yong-wei, LIU Ji-yong746-751
Advances in research on effects of plant growth regulators on the quality of radix and rhizome medicinal materialsZHANG Teng-teng, QIAN Xin-yue, SUN Jun-jie, REN Ming-jun, TANG Yu-chen, ZHANG Xiao-qian, SHAO Guo-quan, HU Yun-fei752-761
A review on the analytical method optimization of sub-visible particles in high concentration antibody drug products and the operation strategyDING Yi, ZHANG Ya-ting, GUO Huan-huan, XIONG Fei, CHI Jen-chih, QIU Bo762-766
Bioequivalence of prucalopride succinate tablets in Chinese healthy women volunteersCHU Ji-hong, YIN Jun-gang, WU Ting, WAN Yao-yao, YU Jing-mei, JU Wen-zheng, ZOU Jian-dong, LI Chang-yin767-772
Clinical observation of different doses of esketamine combined with propofol in gastroscopyLI Chun-lin, SHEN Yang, XU Ya-fei, ZHANG Zhong-qi773-777
Credibility evaluation of subgroup analysis in clinical trials and its impact on regulatory decisionHUANG Hui-yao, MENG Xin-yu, ZHU Qi, WANG Shu-hang, WU Da-wei, TANG Yu, LI Ning778-783